Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

Clinical trial NCT07190443 · RECRUITING

Trial details

NCT number: NCT07190443
Sponsor: Japanese Foundation for Cancer Research
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Locoregional Recurrence Abemaciclib Endocrine Therapy

Start date: 2025-02-07
Primary completion: 2034-02-06
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.